Kagoshima University Medical and Dental Hospital
Kagoshima, Japan
University hospital in Kagoshima
8 Chome-35-1 Sakuragaoka, Kagoshima, 890-8520
About Kagoshima University Medical and Dental Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Haruhiko Fukuda
4
Hospira, now a wholly owned subsidiary of Pfizer
2
Arcagy Research
1
Celgene
1
Genzyme, a Sanofi Company
1
Gilead Sciences
1
HUYABIO International, LLC.
1
Clinical Trials at Kagoshima University Medical and Dental Hospital
During the past decade, Kagoshima University Medical and Dental Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110
2002-06-01
2014-03-01
Completed
500
Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy
2004-05-01
2016-05-01
Completed
200
Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)
2002-09-01
2010-02-01
Completed
300
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
2005-11-01
2015-04-01
Completed
316
Post-Marketing Clinical Study to Assess Efficacy and Safety of Dexmedetomidine in Post-Operative Patients
2005-11-01
2006-08-01
Completed
85
A Study of Clofarabine in Japanese Paediatric Patients With Relapsed or Refractory Acute Lymphoblastic Leukaemia
2010-08-01
2011-05-01
Completed
7
Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation
2011-07-01
2012-03-01
Completed
162
A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma
2012-11-12
2017-03-21
Completed
26
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kagoshima University Medical and Dental Hospital" #1 sponsor was "Haruhiko Fukuda" with 4 trials, followed by "Hospira, now a wholly owned subsidiary of Pfizer" with 2 trials
sponsored, "Arcagy Research" with 1 trials sponsored, "Celgene" with 1 trials sponsored and "Genzyme, a Sanofi Company"
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kagoshima University Medical and Dental Hospital"
#1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 4 trials as a collaborator, "Maruishi Pharmaceutical" with 2 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator and "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were
collaborators in the rest 10 trials.
Clinical Trials Conditions at Kagoshima University Medical and Dental Hospital
According to Clinical.Site data, the most researched conditions in "Kagoshima University Medical and Dental Hospital" are
"Gastric Neoplasm" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Adult T-Cell Leukemia-Lymphoma" (1 trials), "Conscious Sedation" (1 trials) and "Lymphoma, B-Cell" (1 trials). Many other conditions were trialed in "Kagoshima University Medical and Dental Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Kagoshima University Medical and Dental Hospital
Most popular intervention types in "Kagoshima University Medical and Dental Hospital" are "Drug" (10 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Clofarabine" (1 trials), "DA-9501" (1 trials), "Dexmedetomidine" (1 trials), "Gastrectomy with more than D2 dissection" (1 trials) and "HBI-8000" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kagoshima University Medical and Dental Hospital
The vast majority of trials in "Kagoshima University Medical and Dental Hospital" are
9 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Kagoshima University Medical and Dental Hospital
Currently, there are NaN active trials in "Kagoshima University Medical and Dental Hospital".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Kagoshima University Medical and Dental Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kagoshima University Medical and Dental Hospital, 2 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".